ANG Lifesciences India Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 24.71 | 18.42 | 23.88 |
Operating Expense | 22.68 | 18.03 | 25.89 |
Net Profit | -0.79 | -1.94 | -4.57 |
Net Profit Margin | -3.20 | -10.53 | -19.14 |
Earning Per Share | -0.59 | -1.50 | -3.50 |
EBIDTA | 2.27 | 1.41 | -1.02 |
Effective Tax Rate | TBA | TBA | TBA |
Particulars | Jun 2025 |
---|---|
Revenue | 24.71 |
Operating Expense | 22.68 |
Net Profit | -0.79 |
Net Profit Margin | -3.20 |
Earning Per Share | -0.59 |
EBIDTA | 2.27 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 89.91 | 131.37 | 207.01 |
Operating Expenses Annual | 91.72 | 122.25 | 195.94 |
Operating Profit Annual | 0.64 | 8.22 | 20.91 |
Interest Annual | 7.30 | 9.33 | 10.32 |
Depreciation | 6.27 | 7.75 | 8.52 |
Net Profit Annual | -10.34 | -8.65 | -0.66 |
Tax Annual | -2.59 | -0.22 | 2.73 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 89.91 |
Operating Expenses Annual | 91.72 |
Operating Profit Annual | 0.64 |
Interest Annual | 7.30 |
Depreciation | 6.27 |
Net Profit Annual | -10.34 |
Tax Annual | -2.59 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 0.09 | 0.20 | 0.29 |
Cash Flow from Operations | -2.29 | -13.13 | 26.01 |
Cash Flow from Investing | -1.63 | 20.02 | -9.35 |
Cash Flow from Financing | 3.92 | -7 | -16.75 |
Cash Flow at the End | 0.08 | 0.09 | 0.20 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 0.09 |
Cash Flow from Operations | -2.29 |
Cash Flow from Investing | -1.63 |
Cash Flow from Financing | 3.92 |
Cash Flow at the End | 0.08 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 1.08 | 7.78 | 9.99 |
PBIT Margin (%) | -5.89 | 1.88 | 5.87 |
PBT Margin (%) | -5.12 | 1.69 | 5.33 |
Net PROFIT Margin (%) | -11.50 | -6.58 | -0.32 |
Return On Networth / Equity (%) | -14.37 | -8.72 | -0.46 |
Return On Networth /Employed (%) | -3.80 | 1.71 | 7.81 |
Return On Assets (%) | -7.48 | -5.99 | -0.42 |
Total Debt / Equity (X) | 0.90 | 0.71 | 0.69 |
Asset Turnover Ratio (%) | 0.65 | 0.91 | 1.33 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 1.08 |
PBIT Margin (%) | -5.89 |
PBT Margin (%) | -5.12 |
Net PROFIT Margin (%) | -11.50 |
Return On Networth / Equity (%) | -14.37 |
Return On Networth /Employed (%) | -3.80 |
Return On Assets (%) | -7.48 |
Total Debt / Equity (X) | 0.90 |
Asset Turnover Ratio (%) | 0.65 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 52.63 | 53.35 | 78.68 |
Total Current Assets Annual | 146.57 | 158.37 | 168.21 |
Non Current Assets Annual | 57.87 | 57.35 | 82.60 |
Total Shareholders Funds Annual | 66.81 | 77.07 | 85.54 |
Total Assets Annual | 208.67 | 217.43 | 252.51 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 52.63 |
Total Current Assets Annual | 146.57 |
Non Current Assets Annual | 57.87 |
Total Shareholders Funds Annual | 66.81 |
Total Assets Annual | 208.67 |
EPS (INR)
Expected
0.00
Reported
-1.52
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%